{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:21:45Z","timestamp":1783470105741,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48514-2","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:23:11Z","timestamp":1778246591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease laterality independently predicts survival in stage IIIB cervical cancer in a prospective cohort study from Northeast India"],"prefix":"10.1038","volume":"16","author":[{"given":"Mahendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Barmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimpy","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik Chandra","family":"Bassetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotiman","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Khanikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"3","key":"48514_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"48514_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 8 (2), e191\u2013203 (2020).","journal-title":"Lancet Glob Health"},{"issue":"Suppl 2","key":"48514_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla, N., Aoki, D., Sharma, D. N. & Sankaranarayanan, R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 143 (Suppl 2), 22\u201336 (2018).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"48514_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla, N. et al. Revised FIGO staging for carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 145 (1), 129\u2013135 (2019).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"48514_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/ol.2020.12190","volume":"20","author":"A Gadducci","year":"2020","unstructured":"Gadducci, A. & Guerrieri, M. E. Treatment options in recurrent cervical cancer (Review). Oncol. Lett. 20 (6), 327 (2020).","journal-title":"Oncol. Lett."},{"issue":"15","key":"48514_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose, P. G. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl. J. Med. 340 (15), 1144\u20131153 (1999).","journal-title":"N Engl. J. Med."},{"issue":"15","key":"48514_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"M Morris","year":"1999","unstructured":"Morris, M. et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl. J. Med. 340 (15), 1137\u20131143 (1999).","journal-title":"N Engl. J. Med."},{"issue":"8","key":"48514_CR8","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters","year":"2000","unstructured":"Peters, W. A. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cervical cancer. J. Clin. Oncol. 18 (8), 1606\u20131613 (2000).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"48514_CR9","first-page":"339","volume":"67","author":"D Pradhan","year":"2017","unstructured":"Pradhan, D. et al. Hydronephrosis as a prognostic factor in advanced carcinoma cervix. J. Obstet. Gynaecol. India. 67 (5), 339\u2013344 (2017).","journal-title":"J. Obstet. Gynaecol. India"},{"issue":"1","key":"48514_CR10","first-page":"77","volume":"30","author":"P Naga Ch","year":"2020","unstructured":"Naga Ch, P. et al. FIGO stage IIIC cervical cancer: Outcomes of patients with pelvic lymph node metastases treated with radical chemoradiotherapy. Int. J. Gynecol. Cancer. 30 (1), 77\u201382 (2020).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"24","key":"48514_CR11","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1200\/JCO.2012.47.3520","volume":"31","author":"S Gouy","year":"2013","unstructured":"Gouy, S. et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer and para-aortic lymph node involvement treated with extended-field chemoradiation. J. Clin. Oncol. 31 (24), 3023\u20133030 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"48514_CR12","first-page":"805","volume":"56","author":"T Ohno","year":"2015","unstructured":"Ohno, T. et al. A questionnaire-based survey on 3D image-guided brachytherapy for cervical cancer in Japan: Advances and obstacles. J. Radiat. Res. 56 (4), 805\u2013811 (2015).","journal-title":"J. Radiat. Res."},{"issue":"1","key":"48514_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3802\/jgo.2015.26.1.32","volume":"26","author":"S Mabuchi","year":"2015","unstructured":"Mabuchi, S. et al. Impact of histological subtype on survival of patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. J. Gynecol. Oncol. 26 (1), 32\u201339 (2015).","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"48514_CR14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2004.10.021","volume":"96","author":"H Park","year":"2005","unstructured":"Park, H. et al. Prognostic significance of lateral parametrial involvement in patients with locally advanced cervical cancer treated with radiotherapy. Gynecol. Oncol. 96 (2), 402\u2013407 (2005).","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"48514_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose, P. G. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (15), 1144\u20131153 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"48514_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/IGC.0000000000000837","volume":"27","author":"KC Lee","year":"2017","unstructured":"Lee, K. C. et al. The predictive value of tumor size, volume, and markers during radiation therapy in patients with cervical cancer. Int. J. Gynaecol. Cancer. 27 (1), 123\u2013130 (2017).","journal-title":"Int. J. Gynaecol. Cancer"},{"issue":"1","key":"48514_CR17","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3802\/jgo.2018.29.e11","volume":"29","author":"K Matsuo","year":"2017","unstructured":"Matsuo, K. et al. Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB\u2013IIB cervical cancer. J. gynecologic Oncol. 29 (1), e11 (2017).","journal-title":"J. gynecologic Oncol."},{"key":"48514_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla, N., Aoki, D., Sharma, D. N. & Sankaranarayanan, R. Cancer of the cervix uteri. Int. J. Gynecol. Obstet. 143, 22\u201336 (2018).","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"5","key":"48514_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","volume":"22","author":"PJ Eifel","year":"2004","unstructured":"Eifel, P. J. et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u2009\u2013\u200901. J. Clin. Oncol. 22 (5), 872\u2013880 (2004).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"48514_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/0360-3016(94)00635-X","volume":"32","author":"DG Petereit","year":"1995","unstructured":"Petereit, D. G. et al. The adverse effect of treatment prolongation in cervical carcinoma. Int. J. Radiation Oncology* Biology* Phys. 32 (5), 1301\u20131307 (1995).","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"issue":"15","key":"48514_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys, H. M. et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 (15), 1154\u20131161 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"48514_CR22","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/cancers13225748","volume":"13","author":"M Fleischmann","year":"2021","unstructured":"Fleischmann, M. et al. Molecular markers to predict prognosis and treatment response in uterine cervical cancer. Cancers 13 (22), 5748 (2021).","journal-title":"Cancers"},{"key":"48514_CR23","first-page":"100","volume":"14","author":"BH Chang","year":"2007","unstructured":"Chang, B. H. et al. 592 CLL 593 T cell lymphoma 593 Myeloma Cancer in AIDS 593 Malignancies in HIV: The Indian. Biol. Blood Marrow Transpl. 14, 100\u2013107 (2007).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"48514_CR24","first-page":"288","volume":"16","author":"M Klobocista","year":"2018","unstructured":"Klobocista, M., Einstein, M. H. & Runowicz, C. D. Cervical cancer. The American Cancer Society\u2019s Oncology in Practice: Clinical Management. 16, 288\u2013303 (2018).","journal-title":"Apr"},{"key":"48514_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ijgo.70277","volume":"171","author":"N Bhatla","year":"2025","unstructured":"Bhatla, N., Aoki, D., Sharma, D. N. & Sankaranarayanan, R. Cancer of the cervix uteri: 2025 update. Int. J. Gynecol. Obstet. 171, 87\u2013108 (2025).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"48514_CR26","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/PGP.0000000000000553","volume":"38","author":"CJ Stewart","year":"2019","unstructured":"Stewart, C. J. et al. Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites. Int. J. Gynecol. Pathol. 38, S75\u201392 (2019).","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"19","key":"48514_CR27","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1200\/JCO.2006.09.4532","volume":"25","author":"PG Rose","year":"2007","unstructured":"Rose, P. G. et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study. J. Clin. Oncol. 25 (19), 2804\u20132810 (2007).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48514-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:10:48Z","timestamp":1783469448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48514-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The institutional ethical committee of Dr Bhubaneswar Borooah Cancer Institute, Guwahati, approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"21124"}}